ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.
Saved in:
| Title: | ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake. |
|---|---|
| Authors: | Liu Y; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Chen J; Department of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. HMU_chenjingyu@hotmail.com., Ma L; Radio-chemotherapy Department, The First Hospital of Qiqihar, Qiqihar, China., Zhao S; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Hui X; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Xiong W; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China., Cheng S; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China. shaoqiangcheng2023@163.com., Zhang Y; Breast cancer Diagnosis and Treatment Center, Harbin Medical University Cancer Hospital, Harbin, China. zhangyue010@hotmail.com. |
| Source: | Cell biology and toxicology [Cell Biol Toxicol] 2025 Jul 16; Vol. 41 (1), pp. 117. Date of Electronic Publication: 2025 Jul 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 8506639 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6822 (Electronic) Linking ISSN: 07422091 NLM ISO Abbreviation: Cell Biol Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
